Consequently, MSLN-deficient mice are less susceptible to liver fibrosis compared to wild-type mice112, and conditional ablation of mesothelial-derived MSLN+ portal fibroblasts in bile duct-injured mice show significantly reduced liver fibrosis113. Here, MSLN is linked to Hepatic fibrosis.